KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $112,725 | -38.4% | 42,378 | -45.2% | 0.00% | – |
| Q4 2023 | $183,118 | +433.5% | 77,265 | +215.2% | 0.00% | – |
| Q3 2023 | $34,321 | -91.4% | 24,515 | -81.4% | 0.00% | – |
| Q2 2023 | $398,424 | +288.4% | 131,493 | +701.2% | 0.00% | – |
| Q1 2023 | $102,569 | +33.8% | 16,411 | +30.6% | 0.00% | – |
| Q4 2022 | $76,671 | -47.8% | 12,569 | +8.0% | 0.00% | – |
| Q2 2022 | $147,000 | -39.0% | 11,636 | +92.4% | 0.00% | – |
| Q4 2020 | $241,000 | – | 6,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|